Close
4

Seqens Seqens

X

Company profile for MYR Pharmaceuticals

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
MYR Pharma is focused on the development of Myrcludex B, a first-in-class entry inhibitor for treatment of chronic hepatitis B and D infections. The drug targets the protein NTCP on the hepatocyte surface and prevents the infection of healthy cells and viral spreading within the liver. Myrcludex B has shown an excellent safety profile and antiviral efficacy in several clinical trials. The drug has received Orphan Designatio...
MYR Pharma is focused on the development of Myrcludex B, a first-in-class entry inhibitor for treatment of chronic hepatitis B and D infections. The drug targets the protein NTCP on the hepatocyte surface and prevents the infection of healthy cells and viral spreading within the liver. Myrcludex B has shown an excellent safety profile and antiviral efficacy in several clinical trials. The drug has received Orphan Designations for the treatment of HDV infection from EMA and FDA. Myrcludex B has been added to a short list of drugs eligible for the PRIME (PRIority MEdicine) scheme by the European Medicines Agency

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
MYR Pharmaceuticals
Germany Flag
Country
Country
Germany
Address
Address
Thomasstr. 10-12 61348 Bad Homburg
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY